Breast Cancer

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer

  This entry describes a real-world clinical trial of Inavolisib for HR-positive/HER2-negative, PIK3CA-mutated advanced breast cancer, with re…

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery [NA]

  This entry reports on a clinical trial evaluating a telerehabilitation program to manage complications after breast cancer surgery; the stud…

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Cancer Activity and Lifestyle Measurement Study

  This clinical trial update describes an ongoing breast cancer study called Cancer Activity and Lifestyle Measurement Study. It is sponsored …

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery [NA]

  This clinical trial compares a visual biofeedback program with conventional physiotherapy to improve shoulder mobility, strength, and functi…

• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer [Phase 2]

  Phase 2 clinical trial update assessing the combination of durvalumab with trastuzumab and pertuzumab in HER2-enriched breast cancer, with r…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer [Phase 3]

  A Phase 3 clinical trial compares tucatinib versus placebo, both with trastuzumab and pertuzumab, in patients with metastatic HER2-positive …

• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation [Phase 2]

  Phase 2 clinical trial update for ASTRAEA investigating a combination of myeloid inhibition and radiation in metastatic triple-negative brea…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer [Phase 2]

  Phase II study assessing the efficacy and safety of Inavolisib in combination with ribociclib and fulvestrant versus placebo combination in …

• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

  A clinical trial update on Inavolisib evaluating its effectiveness and safety in endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-nega…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation [Phase 2]

  Phase 2 study evaluating a combination of myeloid inhibition and radiation to enhance immunotherapy responses in triple-negative breast canc…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

  This clinical trial update describes genetic, behavioral, laboratory and epidemiologic characterization of individuals and families at high …

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases [Phase 2]

  A Phase 2 clinical trial evaluating brain radiotherapy combined with dalpiciclib and endocrine therapy for HR-positive/HER2-negative advance…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating Zunsemetinib in combination with capecitabine for hormone receptor-positive, HER2-negative metastatic breast ca…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Real-World Study on the Impact of Different Adjuvant Treatment Regimens on Prognosis in Non-pCR Patients With HER2-Positive Breast Cancer After Neoadjuvant Therapy

  This clinical trial update describes a real-world study evaluating the impact of various adjuvant regimens on prognosis in non-pCR patients …

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors [Phase 1]

  Phase 1 study of LOXO-783 in breast cancer and other solid tumors; the trial is currently active but not recruiting.

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors [Phase 1]

  Phase 1 trial update evaluating PF-08032562 in people with advanced or metastatic solid tumors, including breast cancer and colorectal cance…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]

  Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Hypofractionated Regional Nodal Irradiation in Breast Cancer [NA]

  Clinical trial update for a study on hypofractionated regional nodal irradiation in breast cancer; the trial is currently not recruiting.

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

  Clinical trial evaluating the impact of physical activity on outcomes in early-stage hormone receptor-positive breast cancer; currently recr…

• CLINICAL_TRIALS trial_result · 2026-04-20
  Clinical Trial Update: Breast Mammogram and Tissue Study

  A completed clinical trial update focusing on breast mammography and tissue analysis in breast cancer.

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer [NA]

  A clinical trial update describing a study to evaluate how alternative and complementary therapies affect adherence in patients treated with…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer [Phase 2]

  Phase 2 multicohort trial evaluating toripalimab in combination with investigator-selected chemotherapy for advanced HER2-negative breast ca…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: LiveWell mBC Pilot RCT [NA]

  The update describes a LiveWell metastatic breast cancer pilot randomized trial. It is currently not yet recruiting.

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

  A non-interventional study sponsored by Novartis is evaluating the effectiveness and safety of ribociclib as adjuvant therapy for HR-positiv…

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) [Phase 3]

  A Phase 3 trial (CAPItello-292) evaluating capivasertib in combination with a CDK4/6 inhibitor and fulvestrant for advanced/metastatic HR+/H…